SCHEMBL7693446

SCHEMBL7693446

CC(C)(C)N[C@@H](CO)Cc1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.50
SLC6A2 P23975 2/20 0.44
CHRNA1 P02708 1/20 0.44
CHRNG P07510 1/20 0.44
ITGA5 P08648 1/20 0.44
CHRNB1 P11230 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
SLC6A4 P31645 1/20 0.44
CHRNA3 P32297 1/20 0.44
CYP2C19 P33261 1/20 0.44
HRH1 P35367 1/20 0.44
CHRNA7 P36544 1/20 0.44
OPRK1 P41145 1/20 0.44
CHRNA4 P43681 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CHRND Q07001 1/20 0.44
KCNH2 Q12809 1/20 0.44
ALDH1A1 P00352 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7696707 1.00 PNMT (0.50) PNMTSLC6A2CHRNA1CHRNGITGA5
SCHEMBL7692070 1.00 PNMT (0.50) PNMTSLC6A2CHRNA1CHRNGITGA5
Hydrochloric Acid SCHEMBL7693434 0.98 PNMT (0.49) PNMTSLC6A2CHRNA1CHRNGITGA5
SCHEMBL7745210 0.81 MME (0.44) SLC6A2SLC6A4HRH1CHRNA4SLC6A3
SCHEMBL7745276 0.80 MAPK1 (0.53) CYP2C19ALDH1A1TAAR1
SCHEMBL10245188 0.80 MAPK1 (0.53) CYP2C19ALDH1A1TAAR1
SCHEMBL8254401 0.80 MAPK1 (0.53) CYP2C19ALDH1A1TAAR1
SCHEMBL7704772 0.80 PNMT (0.59) PNMTSLC6A2CHRNA1CHRNGITGA5
SCHEMBL1228262 0.80 PNMT (0.59) PNMTSLC6A2CHRNA1CHRNGITGA5
Hydrochloric Acid SCHEMBL7714557 0.78 PNMT (0.57) PNMTSLC6A2CHRNA1CHRNGITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1259243-A2 BUPROPION METABOLITES AND METHODS OF THEIR SYNTHESIS AND USE SEPRACOR, INC. (US) 2002-11-27 EP claimed
WO-2001062257-A2 BUPROPION METABOLITES AND METHODS OF THEIR SYNTHESIS AND USE SEPRACOR INC. (US) 2001-08-30 WO claimed
EP-3538110-A1 METHODS FOR DRUG DISCOVERY USING STEM CELL-DERIVED SCHWANN CELLS Memorial Sloan-Kettering Cancer Center (US) 2019-09-18 EP disclosed
WO-2018090006-A1 METHODS FOR DRUG DISCOVERY USING STEM CELL-DERIVED SCHWANN CELLS MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2018-05-17 WO disclosed